These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2026299)

  • 1. [Serous papillary adenocarcinoma of the endometrium].
    Lampe B; Kürzl R; Kindermann G
    Geburtshilfe Frauenheilkd; 1991 Jan; 51(1):45-50. PubMed ID: 2026299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
    Zheng W; Liang SX; Yu H; Rutherford T; Chambers SK; Schwartz PE
    Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine papillary serous carcinoma: patterns of metastatic spread.
    Goff BA; Kato D; Schmidt RA; Ek M; Ferry JA; Muntz HG; Cain JM; Tamimi HK; Figge DC; Greer BE
    Gynecol Oncol; 1994 Sep; 54(3):264-8. PubMed ID: 8088602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
    Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A risk score for operated endometrial cancer and its importance for adjuvant radiotherapy (histopathology and results of treatment based on 208 cases with pelvic lymph node excision)].
    Kucera H; Vavra N
    Geburtshilfe Frauenheilkd; 1991 Oct; 51(10):798-805. PubMed ID: 1761168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic characterization of uterine papillary serous adenocarcinoma.
    Miller B; Umpierre S; Tornos C; Burke T
    Gynecol Oncol; 1995 Mar; 56(3):425-9. PubMed ID: 7705679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
    Bristow RE; Asrari F; Trimble EL; Montz FJ
    Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients.
    Grice J; Ek M; Greer B; Koh WJ; Muntz HG; Cain J; Tamimi H; Stelzer K; Figge D; Goff BA
    Gynecol Oncol; 1998 Apr; 69(1):69-73. PubMed ID: 9571001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma.
    Rosenberg P; Blom R; Högberg T; Simonsen E
    Gynecol Oncol; 1993 Dec; 51(3):311-5. PubMed ID: 8112638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
    Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
    Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes.
    Zheng W; Cao P; Zheng M; Kramer EE; Godwin TA
    Gynecol Oncol; 1996 May; 61(2):167-74. PubMed ID: 8626128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in adenocarcinoma of the endometrium].
    Giordana C; Malinverni G; Rosmino C; Del Tetto F; Ravarino N; Sala S
    Radiol Med; 1991 Mar; 81(3):342-5. PubMed ID: 2014343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression.
    Nordström B; Strang P; Lindgren A; Bergström R; Tribukait B
    Anticancer Res; 1996; 16(2):899-904. PubMed ID: 8687148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-cytological study of uterine papillary serous carcinoma.
    Hagiwara T; Kaku T; Kobayashi H; Hirakawa T; Nakano H
    Cytopathology; 2005 Jun; 16(3):125-31. PubMed ID: 15924607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
    Sun X; Shi S; Sheng X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome.
    Lim P; Al Kushi A; Gilks B; Wong F; Aquino-Parsons C
    Cancer; 2001 Feb; 91(4):752-7. PubMed ID: 11241243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
    Carcangiu ML; Chambers JT
    Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between pretreatment prognostic factors and lymph node metastases in endometrial adenocarcinoma. Clinical application.
    La Fianza A; Alberici E; Generoso P; Preda L; Campani R
    Radiol Med; 2000 Nov; 100(5):363-6. PubMed ID: 11213416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma.
    Hendrickson M; Ross J; Eifel P; Martinez A; Kempson R
    Am J Surg Pathol; 1982 Mar; 6(2):93-108. PubMed ID: 7102898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.